Corbus Pharmaceuticals Holdings Inc
CRBP
Market Cap$383.83M
Close$
$-1.61
104.3% downside
Current Fair Value
104.3% downsideOvervalued by 104.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $383.83 Million |
|---|---|
| Enterprise Value | $305.68 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.37 |
| Beta | 1.16 |
| Outstanding Shares | 10,507,237 |
| Avg 30 Day Volume | 235,209 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.41 |
|---|---|
| PEG | -43.93 |
| Price to Sales | - |
| Price to Book Ratio | 6.28 |
| Enterprise Value to Revenue | 346.69 |
| Enterprise Value to EBIT | -5.46 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
ESG Score
No data
About Corbus Pharmaceuticals Holdings Inc
CEO: Yuval Cohen